Anjali Advani, M.D.
| Appointed: |
2002 |
| Gender: |
Female |
| Languages: |
English |
Hematologic Oncology and Blood Disorders
Solid Tumor Oncology
Translational Hematology and Oncology Research
Biographical Sketch
Anjali S. Advani, MD, is a Staff Physician in the Department of Hematologic Oncology and Blood Disorders and Director of the Inpatient Leukemia Program, Taussig Cancer Institute. She is also Assistant Professor in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
She completed her medical degree, internal medicine residency and hematology/oncology fellowship at Duke University Medical Center. She has been at Cleveland Clinic since 2002.
Dr. Advani's major clinical interests include myelodysplasia and acute leukemias, with a particular emphasis on molecular targeted therapies and novel treatment strategies for acute myeloid leukemia and acute lymphocytic leukemia.
She is a member of the Southwest Oncology Group Leukemia Committee and serves as Co-Chair for the Data Safety and Monitoring Board committee for clinical trials at the Case Comprehensive Cancer Center.
Professional Highlights
- Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
- Co-Chair, Data and Safety Monitoring Board, Case Comprehensive Cancer Center
Education & Fellowships
| Medical School: | Duke University School of Medicine, Durham, NC |
|
| Residency: | Duke University Medical Center, Internal Medicine, Durham, NC |
| Fellowship: | Duke University Medical Center, Hematology/Oncology, Durham, NC |
| Other Education: | (Undergraduate) Princeton University, Princeton, NJ |
Certifications
Hematology
Medical Oncology
Internal Medicine
Specialty Interests
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia.
Awards & Honors
Teacher of the Year Award, Hematology/Oncology, 2006-2007
Professional Memberships
- Southwest Oncology Group Leukemia Committee
- American Society of Hematology
- American Society of Clinical Oncology
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/4/2008, Dr. Advani has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
